Cyclic olefin-based copolymer, cyclic olefin-based copolymer composition, molded article, and medical container

US12240930B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12240930-B2
Application numberUS-202318157892-A
CountryUS
Kind codeB2
Filing dateJan 23, 2023
Priority dateNov 29, 2017
Publication dateMar 4, 2025
Grant dateMar 4, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described is a cyclic olefin-based copolymer has a constitutional unit (A) derived from an α-olefin having 2 to 20 carbon atoms, a constitutional unit (B) derived from a cyclic olefin without an aromatic ring, and a constitutional unit (C) derived from a cyclic olefin having an aromatic ring. Also described is a medical container containing a cyclic olefin-based copolymer having a constitutional unit (A) derived from an α-olefin having 2 to 20 carbon atoms, a constitutional unit (B) derived from a cyclic olefin without an aromatic ring, and a constitutional unit (C) derived from a cyclic olefin having an aromatic ring.

First claim

Opening claim text (preview).

The invention claimed is: 1. A medical container comprising: a cyclic olefin-based copolymer having a constitutional unit (A) derived from an α-olefin having 2 to 20 carbon atoms, a constitutional unit (B) derived from a cyclic olefin without an aromatic ring, and a constitutional unit (C) derived from a cyclic olefin having an aromatic ring, wherein the cyclic olefin having an aromatic ring contains at least one kind of compound selected from benzonorbornadiene, indene norbornene, and methyl phenyl norbornene. 2. The medical container according to claim 1 , wherein in a case where a total content of the constitutional unit (A), the constitutional unit (B), and the constitutional unit (C) in the cyclic olefin-based copolymer is 100 mol %, a content of the constitutional unit (C) in the cyclic olefin-based copolymer is equal to or greater than 0.1 mol % and equal to or smaller than 50 mol %. 3. The medical container according to claim 1 , wherein in a case where a total content of the constitutional unit (B) and the constitutional unit (C) in the cyclic olefin-based copolymer is 100 mol %, a content of the constitutional unit (C) in the cyclic olefin-based copolymer is equal to or greater than 5 mol % and equal to or smaller than 95 mol %. 4. The medical container according to claim 1 , wherein in a case where a total content of the constitutional unit (A), the constitutional unit (B), and the constitutional unit (C) in the cyclic olefin-based copolymer is 100 mol %, a content of the constitutional unit (A) in the cyclic olefin-based copolymer is equal to or greater than 10 mol % and equal to or smaller than 80 mol %. 5. The medical container according to claim 1 , wherein the cyclic olefin without an aromatic ring contains a compound represented by the following Formula (B-1), in Formula [B-1], n is 0 or 1, m is 0 or a positive integer, q is 0 or 1, R 1 to R 18 , R a , and R b each independently represent a hydrogen atom, a halogen atom, or a hydrocarbon group which may be substituted with a halogen atom, R 15 to R 18 may form a monocyclic ring or a polycyclic ring by being bonded to each other, the monocyclic ring or the polycyclic ring may have a double bond, R 15 and R 16 or R 17 and R 18 may form an alkylidene group, and the compound represented by Formula [B-1] does not have an aromatic ring. 6. The medical container according to claim 1 , wherein a glass transition temperature (Tg) of the cyclic olefin-based copolymer measured using a differential scanning calorimeter (DSC) is equal to or higher than 120° C. and equal to or lower than 180° C. 7. The medical container according to claim 1 that is a syringe or a liquid medicine storage container.

Assignees

Inventors

Classifications

  • C08F232/08Primary

    having condensed rings (coumarone-indene polymers C08F244/00) · CPC title

  • Ethene · CPC title

  • Lenses · CPC title

  • as molar percentages · CPC title

  • for materials not otherwise provided for · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12240930B2 cover?
Described is a cyclic olefin-based copolymer has a constitutional unit (A) derived from an α-olefin having 2 to 20 carbon atoms, a constitutional unit (B) derived from a cyclic olefin without an aromatic ring, and a constitutional unit (C) derived from a cyclic olefin having an aromatic ring. Also described is a medical container containing a cyclic olefin-based copolymer having a constitutiona…
Who is the assignee on this patent?
Mitsui Chemicals Inc
What technology area does this patent fall under?
Primary CPC classification C08F232/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).